Shandong Xinhua Pharmaceutical (00719) has issued an announcement stating that the Board of Directors has resolved to propose Mr. Liu Weimin (Mr. Liu) as a candidate for appointment as an executive director, subject to approval by the Company's shareholders at an extraordinary general meeting to be held on or around November 10, 2026, based on the recommendation put forward by the Board's nomination committee.